← Leaderboards
Ralph Alphonso Pantophlet
Simon Fraser University
$4,351,151
Attributed
$4,351,151
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $717.7K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,351,151 · 3
By mechanism
R01$3,767,467 · 1
R21$583,684 · 2
Top collaborators
No co-investigators on record.
Most similar at Simon Fraser University
Same institution · by research overlap
- Jamie K Scott$2,624,231
- Felix J Breden$428,400
Others in their field
Top investigators on “Neutralizing Antibody”
- Barton F Haynes · Duke University$361,488,167
- Dennis R. Burton · Scripps Research Institute$328,455,703
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,392,049
- Lawrence Corey · Fred Hutchinson Cancer Center$257,355,255
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$139,509,763
Research focus
Neutralizing AntibodyDesignHiv VaccineSiteSpecificityAntibodiesHiv Envelope Protein Gp120PolysaccharidesMimicryReportingImmunizationAntibody ResponseImmunizeOligosaccharidesAvidityInvestigationBindingB-LymphocytesCross ReactivityGlycoconjugatesHiv-1EpitopesAffinityImmune System
Grant awards (12)
Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1$487,745
R01 · FY2025 · AI · contact PI
Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1$487,746
R01 · FY2024 · AI · contact PI
Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1$539,999
R01 · FY2023 · AI · contact PI
Adjuvant, mimicry and booster requirements for shepherding the development of neutralizing antibodies to the high-mannose patch on HIV-1$545,999
R01 · FY2022 · AI · contact PI
Relevance of serum mannosidase resistance to the specificity of oligomannose-targeting antibodies$171,731
R21 · FY2022 · AI · contact PI
Relevance of serum mannosidase resistance to the specificity of oligomannose-targeting antibodies$116,610
R21 · FY2021 · AI · contact PI
Synthetic bacterial analogs of mammalian oligomannose for eliciting neutralizing antibodies to the high-mannose patch on HIV Env$539,341
R01 · FY2020 · AI · contact PI
Synthetic bacterial analogs of mammalian oligomannose for eliciting neutralizing antibodies to the high-mannose patch on HIV Env$505,735
R01 · FY2019 · AI · contact PI
Synthetic bacterial analogs of mammalian oligomannose for eliciting neutralizing antibodies to the high-mannose patch on HIV Env$330,451
R01 · FY2018 · AI · contact PI
Synthetic bacterial analogs of mammalian oligomannose for eliciting neutralizing antibodies to the high-mannose patch on HIV Env$330,451
R01 · FY2017 · AI · contact PI
Exploring antibody recognition of the V3 region on HIV-1 to guide vaccine design$149,111
R21 · FY2010 · AI · contact PI
Exploring antibody recognition of the V3 region on HIV-1 to guide vaccine design$146,232
R21 · FY2009 · AI · contact PI